Internal Medicine, Gastroenterology · Houston, TX
NPI
1114269305
Since 2013
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
7919 Kirby Dr
Houston, TX, 77054
Phone (713) 393-7744
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
451 services
Medicare patients, 2024
140
Average age 70
Drug cost, 2024
$2.3M
4,037 prescriptions
Company payments, 2025
$1,136
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmad Farooq was code 99204 (office e&m - new), 65 times for 64 patients. In total Ahmad Farooq billed 451 services in 23 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99204 Office E&M - New | Office | 65 | 64 | $119.27 | $7,753 |
| 99443 Telephone Services | Office | 58 | 50 | $98.63 | $5,721 |
| 99214 Office E&M - Established | Office | 57 | 48 | $93.73 | $5,343 |
| 76981 Ultrasound - Nonspecific | Office | 50 | 47 | $77.50 | $3,875 |
| 45385 Colonoscopy - Lesion Removal | Facility | 36 | 34 | $133.26 | $4,797 |
| 45380 Lower GI Endoscopy - Other | Facility | 27 | 26 | $34.07 | $920 |
| 43239 Upper GI Endoscopy | Office | 20 | 17 | $59.23 | $1,185 |
| 43239 Upper GI Endoscopy | Facility | 18 | 16 | $39.81 | $717 |
| 45390 Lower GI Endoscopy - Other | Facility | 16 | 16 | $253.05 | $4,049 |
| 99213 Office E&M - Established | Office | 15 | 14 | $56.30 | $845 |
| 99203 Office E&M - New | Office | 14 | 14 | $84.47 | $1,183 |
| 45385 Colonoscopy - Lesion Removal | Office | 11 | 11 | $136.69 | $1,504 |
By year: 2022 $43K for 482 services; 2023 $26K for 272 services; 2024 $49K for 451 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahmad Farooq prescribed most often to Medicare patients was Gavilyte-C (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 1,642 prescriptions and refills. In total Ahmad Farooq wrote 4,037 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 1,642 | 1,646 | 1,457 | $26K |
| Omeprazole Generic | 557 | 1,454 | 439 | $6,493 |
| Pantoprazole Sodium Generic | 399 | 1,166 | 299 | $6,194 |
| Linzess Linaclotide | 163 | 422 | 82 | $218K |
| Metronidazole Generic | 133 | 133 | 124 | $901 |
| Amoxicillin Generic | 107 | 107 | 99 | $333 |
| Clarithromycin Generic | 86 | 86 | 83 | $1,891 |
| Hydrocortisone Generic | 84 | 84 | 66 | $1,430 |
| Sucralfate Generic | 61 | 61 | 37 | $4,233 |
| Metoclopramide Hcl Generic | 60 | 64 | 36 | $285 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 47 | 47 | 47 | $962 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 45 | 45 | 43 | $671 |
| Cholestyramine Light Cholestyramine | 39 | 59 | 24 | $2,990 |
| Mavyret Glecaprevir/Pibrentasvir | 39 | 39 | 20 | $507K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 37 | 37 | 35 | $545 |
Brand drugs: 417 claims; generic drugs: 3,620 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmad Farooq $1,136 ($1,136 in general payments such as food, travel and fees) from 9 companies. The largest payer was Madrigal Pharmaceuticals with $387.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 23 | $387 |
| Gilead Sciences, Inc. GILD | 10 | $299 |
| Abbvie Inc. ABBV | 12 | $211 |
| Aimmune Therapeutics, Inc. | 3 | $88.26 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $48.39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $44.82 |
| Pfizer Inc. PFE | 1 | $25.98 |
| CapsoVision, Inc. CV | 1 | $16.77 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $14.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.